Why the study?
Patients with hypertrophic cardiomyopathy are prone to body weight increase and obesity, but whether this predisposes them to long-term adverse outcomes remains unresolved.
Does obesity increase the risk of adverse long-term outcomes in patients with hypertrophic cardiomyopathy?
Population
3282 patients with HCM from an international multicenter registry
Comparison
Obesity (>30) vs preobesity (25-30) vs normal weight (<25) BMI groups
Design
Retrospective cohort study
Follow-up
Median 6.8 years
Authors
Loading...
Higher BMI may associate with worse HCM outcomes; hypothesis-generating and should not yet change practice.
Does obesity increase the risk of adverse long-term outcomes in patients with hypertrophic cardiomyopathy?
In patients with hypertrophic cardiomyopathy, obesity is independently associated with a significantly higher risk of heart failure and overall adverse composite outcomes.
Fumagalli et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: